TherVacB Project Begins Patient Trial to Advance Curative Strategy for Chronic Hepatitis B
Chronic hepatitis B virus (HBV) infection remains a significant global health concern, affecting an estimated 254 million people worldwide and contri1
Chronic hepatitis B virus (HBV) infection remains a significant global health concern, affecting an estimated 254 million people worldwide and contri1
Drs. Maria Carlota Londoño and Sabela Lens, hepatologists at Hospital Clínic and researchers in the Viral, Genetic and Immuno-mediated Liver Diseases1
An international study led by María-Carlota Londoño, a member of the IDIBAPS research group Viral genetic and immune mediated liver diseases, has ide1
Hepatitis Delta is a chronic disease caused by infection with the Hepatitis D virus (HDV), a highly unusual pathogen that requires the Hepatitis B vi1
The work, led by researchers from the Clínic-IDIBAPS and the Hospital la Fe in Valencia, has been published in the journal Hepatology.
IDIBAPS looks for talented professionals to meet the needs that appear periodically.
Enter